$2.59 Billion is the total value of Artal Group S.A.'s 99 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $566,207,000 | +1.0% | 14,818,300 | 0.0% | 21.88% | -2.6% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $249,999,000 | +37.9% | 60,240,864 | 0.0% | 9.66% | +32.8% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $95,445,000 | +26.8% | 450,000 | 0.0% | 3.69% | +22.2% | |
| MRNA | MODERNA INC | $90,099,000 | +22.9% | 4,606,298 | 0.0% | 3.48% | +18.4% | |
| FATE | FATE THERAPEUTICS INC | $39,140,000 | +26.0% | 2,000,000 | 0.0% | 1.51% | +21.4% | |
| MORF | MORPHIC HLDG INC | $31,217,000 | -5.2% | 1,819,186 | 0.0% | 1.21% | -8.7% | |
| RUBY | RUBIUS THERAPEUTICS INC | $26,921,000 | +21.0% | 2,833,791 | 0.0% | 1.04% | +16.6% | |
| GOSS | GOSSAMER BIO INC | $25,148,000 | -6.9% | 1,608,968 | 0.0% | 0.97% | -10.2% | |
| UBER | UBER TECHNOLOGIES INC | $14,870,000 | -2.4% | 500,000 | 0.0% | 0.57% | -6.1% | |
| AAL | AMERICAN AIRLS GROUP INCcall | $14,340,000 | +6.3% | 500,000 | 0.0% | 0.55% | +2.4% | |
| TCDA | TRICIDA INC | $13,586,000 | +22.3% | 360,000 | 0.0% | 0.52% | +17.7% | |
| PRQR | PROQR THRAPEUTICS N V | $12,883,000 | +72.0% | 1,300,000 | 0.0% | 0.50% | +66.0% | |
| YMAB | Y MABS THERAPEUTICS INC | $12,500,000 | +19.9% | 400,000 | 0.0% | 0.48% | +15.6% | |
| ALBO | ALBIREO PHARMA INC | $11,444,000 | +27.1% | 450,200 | 0.0% | 0.44% | +22.4% | |
| SAGE | SAGE THERAPEUTICS INC | $10,829,000 | -48.5% | 150,000 | 0.0% | 0.42% | -50.5% | |
| AGEN | AGENUS INC | $10,175,000 | +57.8% | 2,500,000 | 0.0% | 0.39% | +51.7% | |
| MRNA | MODERNA INCcall | $9,780,000 | +22.9% | 500,000 | 0.0% | 0.38% | +18.5% | |
| BLUE | BLUEBIRD BIO INC | $8,775,000 | -4.4% | 100,000 | 0.0% | 0.34% | -7.9% | |
| REPL | REPLIMUNE GROUP INC | $8,610,000 | +3.2% | 600,000 | 0.0% | 0.33% | -0.3% | |
| ACIU | AC IMMUNE SA | $8,520,000 | +72.1% | 1,000,000 | 0.0% | 0.33% | +66.2% | |
| NERV | MINERVA NEUROSCIENCES INC | $7,110,000 | -8.3% | 1,000,000 | 0.0% | 0.28% | -11.6% | |
| NIO | NIO INCcall | $7,035,000 | +157.7% | 1,750,000 | 0.0% | 0.27% | +149.5% | |
| MRUS | MERUS N V | $7,040,000 | -21.0% | 500,000 | 0.0% | 0.27% | -23.8% | |
| BBIO | BRIDGEBIO PHARMA INC | $7,010,000 | +63.3% | 200,000 | 0.0% | 0.27% | +57.6% | |
| DNLI | DENALI THERAPEUTICS INC | $6,968,000 | +13.7% | 400,000 | 0.0% | 0.27% | +9.3% | |
| AUTL | AUTOLUS THERAPEUTICS PLCsponsored ads | $6,600,000 | +6.3% | 500,000 | 0.0% | 0.26% | +2.4% | |
| RGNX | REGENXBIO INC | $5,941,000 | +15.1% | 145,000 | 0.0% | 0.23% | +11.1% | |
| LGFA | LIONS GATE ENTMNT CORPcall | $5,330,000 | +15.2% | 500,000 | 0.0% | 0.21% | +11.4% | |
| FOLD | AMICUS THERAPEUTICS INCcall | $4,870,000 | +21.4% | 500,000 | 0.0% | 0.19% | +16.8% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,813,000 | +15.8% | 350,000 | 0.0% | 0.19% | +11.4% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4,488,000 | -3.2% | 150,000 | 0.0% | 0.17% | -7.0% | |
| YI | 111 INCads | $4,375,000 | +38.2% | 650,000 | 0.0% | 0.17% | +33.1% | |
| ALEC | ALECTOR INC | $3,877,000 | +19.5% | 225,000 | 0.0% | 0.15% | +15.4% | |
| STML | STEMLINE THERAPEUTICS INC | $3,827,000 | +2.1% | 360,000 | 0.0% | 0.15% | -1.3% | |
| CYCN | CYCLERION THERAPEUTICS INC | $3,703,000 | -77.6% | 1,361,584 | 0.0% | 0.14% | -78.4% | |
| DOYU | DOUYU INTERNATIONAL HLDNGS Lsponsored ads | $3,388,000 | +3.4% | 400,000 | 0.0% | 0.13% | 0.0% | |
| SGMO | SANGAMO THERAPEUTICS INC | $3,390,000 | -7.5% | 405,000 | 0.0% | 0.13% | -10.9% | |
| VKTX | VIKING THERAPEUTICS INC | $2,807,000 | +16.6% | 350,000 | 0.0% | 0.11% | +11.3% | |
| AKBA | AKEBIA THERAPEUTICS INC | $2,686,000 | +61.2% | 425,000 | 0.0% | 0.10% | +55.2% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,292,000 | -0.7% | 300,000 | 0.0% | 0.09% | -3.3% | |
| TWST | TWIST BIOSCIENCE CORP | $2,100,000 | -12.1% | 100,000 | 0.0% | 0.08% | -15.6% | |
| AXLA | AXCELLA HEALTH INC | $1,805,000 | -29.1% | 450,000 | 0.0% | 0.07% | -31.4% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,471,000 | +55.0% | 110,532 | 0.0% | 0.06% | +50.0% | |
| ADRO | ADURO BIOTECH INC | $1,180,000 | +11.3% | 1,000,000 | 0.0% | 0.05% | +9.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.